Literature DB >> 12654643

Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.

William I Mariencheck1, John F Alcorn, Scott M Palmer, Jo Rae Wright.   

Abstract

Both in vitro and in vivo studies provide evidence that surfactant protein (SP)-A and SP-D have an important role in the innate immune response to Pseudomonas aeruginosa. In preliminary experiments characterizing the binding of SP-A to this bacteria, we observed the appearance of apparent degradation products of SP-A, and therefore we hypothesized that P. aeruginosa produces an enzyme that degrades SP-A. Incubation of SP-A with P. aeruginosa organisms from several clinical isolates resulted in concentration- and temperature-dependent degradation of SP-A that was inhibited by a metalloproteinase inhibitor, phosphoramidon. The degradative enzyme was purified by anion exchange chromatography and identified by ion trap mass spectroscopy as Pseudomonas elastase, which was shown to directly degrade SP-A and SP-D. Incubation of P. aeruginosa or purified elastase with cell-free bronchoalveolar lavage (BAL) resulted in degradation of SP-A. Furthermore, SP-A degradation fragments were detectable in BAL from lung transplant patients with cystic fibrosis. We speculate that degradation of SP-A and SP-D is a virulence mechanism in the pathogenesis of chronic P. aeruginosa infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654643     DOI: 10.1165/rcmb.2002-0141OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

Review 1.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

2.  Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles.

Authors:  Frank Galka; Sun Nyunt Wai; Harald Kusch; Susanne Engelmann; Michael Hecker; Bernd Schmeck; Stefan Hippenstiel; Bernt Eric Uhlin; Michael Steinert
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

Review 3.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 4.  Surfactant and its role in the pathobiology of pulmonary infection.

Authors:  Jennifer R Glasser; Rama K Mallampalli
Journal:  Microbes Infect       Date:  2011-09-10       Impact factor: 2.700

5.  The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

Authors:  Zhizhou Kuang; Yonghua Hao; Sunghei Hwang; Shiping Zhang; Eunice Kim; Henry T Akinbi; Michael J Schurr; Randall T Irvin; Daniel J Hassett; Gee W Lau
Journal:  Mol Microbiol       Date:  2011-01-06       Impact factor: 3.501

Review 6.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

7.  Immunolocalization of Surfactant Proteins SP-A, SP-B, SP-C, and SP-D in Infantile Labial Glands and Mucosa.

Authors:  Mechthild Stoeckelhuber; Friedrich Feuerhake; Christoph Schmitz; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  J Histochem Cytochem       Date:  2018-03-30       Impact factor: 2.479

8.  Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.

Authors:  Stephan W Glasser; Albert P Senft; Jeffrey A Whitsett; Melissa D Maxfield; Gary F Ross; Theresa R Richardson; Daniel R Prows; Yan Xu; Thomas R Korfhagen
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

10.  Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.

Authors:  Floriana Cappiello; Antonio Di Grazia; Li-Av Segev-Zarko; Silvia Scali; Loretta Ferrera; Luis Galietta; Alessandro Pini; Yechiel Shai; Y Peter Di; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.